Author:
Sirokay Judith,Ugurel Selma
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Chen Y‑T, Tu W‑T, Lee W‑R et al (2016) The efficacy of adjuvant radiotherapy in dermatofibrosarcoma protuberans: a systemic review and meta-analysis. J Eur Acad Dermatol Venereol 30(7):1107–1114
2. Dadone-Montaudié B, Alberti L, Duc A et al (2018) Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions. Mod Pathol 31(11):1683–1693
3. Dickson BC, Hornick JL, Fletcher CDM et al (2018) Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast. Genes Chromosomes Cancer 57(9):437–445
4. Fu Y, Kang H, Zhao H et al (2015) Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib. Int J Clin Exp Med 8(5):8288–8294
5. Helbig D, Ihle MA, Pütz K et al (2016) Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas. Oncotarget 7(16):21763–21774